Filter Results:
(3,126)
Show Results For
- All HBS Web
(3,126)
- People (6)
- News (680)
- Research (1,774)
- Events (14)
- Multimedia (14)
- Faculty Publications (898)
Show Results For
- All HBS Web
(3,126)
- People (6)
- News (680)
- Research (1,774)
- Events (14)
- Multimedia (14)
- Faculty Publications (898)
- April 2019 (Revised June 2019)
- Case
Ariadne Labs: Building Impactful Partnerships
By: Ariel D. Stern and Sarah Mehta
In September 2018, the executive team at Ariadne Labs (Ariadne), a Boston-based organization dedicated to improving health systems through the discovery and implementation of simple tools, faced a number of strategic decisions. Chief among them, the seven-year-old... View Details
Keywords: Health; Health Care and Treatment; Innovation and Invention; Social Enterprise; Nonprofit Organizations; Partners and Partnerships; Health Industry; Boston
Stern, Ariel D., and Sarah Mehta. "Ariadne Labs: Building Impactful Partnerships." Harvard Business School Case 619-017, April 2019. (Revised June 2019.)
- Video
Adrian Gore
Adrian Gore, founder and Group Chief Executive of Discovery Limited, outlines a commitment to improving the health of their customers, which has allowed the company to continue building public trust. View Details
- November 3, 2020
- Article
Gender Differences in COVID-19 Attitudes and Behavior: Panel Evidence from Eight Countries
By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard and Martial Foucault
Using original data from two waves of a survey conducted in March and April 2020 in eight OECD countries (N = 21,649), we show that women are more likely to see COVID-19 as a very serious health problem, to agree with restraining public policy measures adopted in... View Details
Galasso, Vincenzo, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard, and Martial Foucault. "Gender Differences in COVID-19 Attitudes and Behavior: Panel Evidence from Eight Countries." Proceedings of the National Academy of Sciences 117, no. 44 (November 3, 2020).
- 11 May 2011
- News
Clinical Registries: The Opportunity For The Nation
- 18 Apr 2024
- Lecture
Innovation Opportunities Created by COVID-19 Can Help: And How to Make Them Happen
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
- 14 Apr 2020
- Video
Perspectives on the COVID-19 Pandemic: Jha-Huckman (Session 2)
- 15 Sep 2009
- News
Insurance supermarket risks
- June 2006 (Revised June 2007)
- Background Note
The Challenge Facing the U.S. Healthcare Delivery System
By: Richard M.J. Bohmer and Carin-Isabel Knoop
Discusses the challenges currently facing the U.S. health care delivery system. These challenges frame the problems managers of delivery organizations are currently facing. They include a burgeoning gap between demand and supply. Demand for health care services is... View Details
Bohmer, Richard M.J., and Carin-Isabel Knoop. "The Challenge Facing the U.S. Healthcare Delivery System." Harvard Business School Background Note 606-096, June 2006. (Revised June 2007.)
- 07 Jan 2020
- Cold Call Podcast
Can Capitalism Be Fixed by Making Companies More Just?
- December 2010
- Case
Oral Rehydration Therapy
By: Nava Ashraf and Claire Qureshi
This case highlights the puzzlingly high rate of diarrhea-related child mortality in developing countries despite the existence of a simple, effective treatment: oral rehydration therapy (ORT). ORT treated extreme dehydration caused by diarrhea, which was a leading... View Details
Keywords: Health Care and Treatment; Innovation Strategy; Problems and Challenges; Developing Countries and Economies; Technological Innovation; Distribution Channels; Emerging Markets; Consumer Behavior; Performance Consistency; Performance Evaluation; Health Industry; Africa; Asia
Ashraf, Nava, and Claire Qureshi. "Oral Rehydration Therapy." Harvard Business School Case 911-035, December 2010. (Request a courtesy copy.)
- 12 Mar 2024
- Research & Ideas
Publish or Perish: What the Research Says About Productivity in Academia
on things like the publication record and grant databases, which are not designed for us to see how science is operating.” Harvard Business School Assistant Professor Kyle Myers and seven colleagues surveyed professor-level researchers at... View Details
- March 2017
- Case
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
By: Kevin Schulman, Sashidaran Moodley and Anant Vasudevan
PharmAccess is an Amsterdam-based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the... View Details
Keywords: Finance; Entrepreneurship; Health Care and Treatment; Online Technology; Health Industry; Africa; Kenya
Schulman, Kevin, Sashidaran Moodley, and Anant Vasudevan. "PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World." Harvard Business School Case 317-103, March 2017.
- 07 Nov 2020
- News
Gender differences in COVID-19 perception and compliance
- 01 Jan 2007
- News
James A. Hamilton Award, American College of Healthcare Executives
John A. Quelch
John A. Quelch is Executive Vice Chancellor and Distinguished Professor of Social Science at Duke Kunshan University. He is also John DeButts Professor at Duke University's Fuqua School of Business. Between 2017 and 2023 he was the Leonard M. Miller University... View Details
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- April 1995 (Revised August 1995)
- Case
Empire Blue Cross and Blue Shield (A)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company. View Details
Keywords: Governing and Advisory Boards; Corporate Governance; Financial Condition; Organizational Culture; Problems and Challenges; Nonprofit Organizations; Insurance Industry
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (A)." Harvard Business School Case 195-216, April 1995. (Revised August 1995.)
- September 2023
- Article
Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic
By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard and Martial Foucault
We study the impact of public health messages on intentions to vaccinate and vaccination uptakes, especially among hesitant groups. We performed an experiment comparing the effects of egoistic and altruistic messages on COVID-19 vaccine intentions and behaviour. We... View Details
Keywords: COVID-19; Vaccination; Vaccine Hesitancy; Information Campaigns; Health Pandemics; Behavior; Information
Galasso, Vincenzo, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard, and Martial Foucault. "Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic." BMJ Global Health 8, no. 9 (September 2023).
- August 2010 (Revised March 2012)
- Case
The UCLA Medical Center: Kidney Transplantation
By: Michael E. Porter, Jennifer F Baron, Jacob Mathew Chacko and Robin Jian Tang
In 2010, organ transplantation remained among the few sets of medical conditions in the U.S. for which bundled payments were a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was... View Details
Keywords: Insurance; Health Care and Treatment; Health Disorders; Measurement and Metrics; Outcome or Result; Competitive Strategy; Integration; Health Industry; California
Porter, Michael E., Jennifer F Baron, Jacob Mathew Chacko, and Robin Jian Tang. "The UCLA Medical Center: Kidney Transplantation." Harvard Business School Case 711-410, August 2010. (Revised March 2012.)